Bridgebio Oncology Therapeutics, Inc. (BBOT)
2.62
-0.08
(-2.96%)
USD |
NASDAQ |
Oct 30, 16:00
2.64
+0.02
(+0.76%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics Price to Book Value : 0.6496 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 0.6496 |
| October 29, 2026 | 0.6695 |
| October 28, 2026 | 0.6943 |
| October 27, 2026 | 0.667 |
| October 26, 2026 | 0.6546 |
| October 23, 2026 | 0.6595 |
| October 22, 2026 | 0.7067 |
| October 21, 2026 | 0.6645 |
| October 20, 2026 | 0.6744 |
| October 19, 2026 | 0.7067 |
| October 16, 2026 | 0.6992 |
| October 15, 2026 | 0.7314 |
| October 14, 2026 | 0.7203 |
| October 13, 2026 | 0.7314 |
| October 12, 2026 | 0.8083 |
| October 09, 2026 | 0.8207 |
| October 08, 2026 | 0.848 |
| October 07, 2026 | 0.8529 |
| October 06, 2026 | 0.8678 |
| October 05, 2026 | 0.8926 |
| October 02, 2026 | 0.9645 |
| October 01, 2026 | 0.9769 |
| September 30, 2026 | 1.017 |
| September 29, 2026 | 0.972 |
| September 28, 2026 | 0.9447 |
| Date | Value |
|---|---|
| September 25, 2026 | 0.9794 |
| September 24, 2026 | 0.9893 |
| September 23, 2026 | 1.032 |
| September 22, 2026 | 1.155 |
| September 21, 2026 | 1.155 |
| September 18, 2026 | 1.183 |
| September 17, 2026 | 1.212 |
| September 16, 2026 | 1.180 |
| September 15, 2026 | 1.21 |
| September 14, 2026 | 1.252 |
| September 11, 2026 | 1.227 |
| September 10, 2026 | 1.369 |
| September 09, 2026 | 1.675 |
| September 08, 2026 | 2.197 |
| September 04, 2026 | 2.227 |
| September 03, 2026 | 2.207 |
| September 02, 2026 | 2.204 |
| September 01, 2026 | 2.187 |
| August 31, 2026 | 2.182 |
| August 28, 2026 | 2.167 |
| August 27, 2026 | 2.276 |
| August 26, 2026 | 2.296 |
| August 25, 2026 | 2.323 |
| August 24, 2026 | 2.266 |
| August 21, 2026 | 2.251 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 3.602 |
| IRulya Therapeutics, Inc. | -- |
| PepGen Inc. | 1.367 |
| Q32 Bio, Inc. | 1.997 |
| Arrowhead Pharmaceuticals, Inc. | 18.16 |
Price to Book Value Related Metrics
| Price | 2.62 |
| Earnings Yield | -47.05K% |
| Market Cap | 209.90M |